Abstract:AIM: To construct and prepare the recombinant adenovirus vector co-expressing angiopoietin-1 (ANG-1) and report gene EGFP. METHODS: The ANG-1 gene was cloned by PCR and then subcloned into vector pAdTrack-CMV which carries the report gene EGFP. The pAdTrack-CMV-ANG-1 and Padeasy-1 were recombined in BJ5183. After identity, the precombinated adenovirus vector of plasmid pAd-ANG-1-EGFP was used to package adenovirus in 293A cells. The identity, titer and EGFP activity of adenovirus were analyzed by methods of PCR, dot-blot and virus infection, respectively. RESULTS: The enzyme digestion of the products with Xho I/EcoR V displayed a fragment at 1.5 kb, suggesting that the recombinant plasmid, pAdTrack-CMV-ANG-1 was constructed successfully. The enzyme digestion of the products with Pac I showed 2 gene fragments: one was about 30 kb, the other was about 4.5 kb, suggesting that the recombinant adenovirus vector, pAd-ANG-1-EGFP, was successfully reconstruced. In 293A cells the recombinant adenovirus vector was successfully packaged. The titer was 2×1014 v.g./L, the positivity rate of adenovirus infected cells was over 30%. CONCLUSION: The recombinant adenovirus vector expressing angiopoietin-1 (ANG-1) is successfully prepared. The virus serves to explore the vascularization in bone tissue engineering.

Construction of recombinant adenovirus vector co-expressing angiopoietin-1 and report gene EGFP